HOME >> MEDICINE >> NEWS
New alzheimer's drug shows promise in clinical trial

Washington, DC--The only drugs currently available for Alzheimer's patients are those that alleviate symptoms, but a team of scientists led by Paul Aisen, MD, director of the Memory Disorders program at Georgetown University Medical Center, is testing a new class of drugs that actually target the molecule believed to cause the disease. Aisen and his colleagues report that a compound called tramiprosate reduced levels of a marker for the progression of Alzheimer's disease in a Phase II clinical trial in the November 1 electronic version of Neurology.

"Everyone wants to figure out how to create an Alzheimer's treatment that attacks the amyloid peptide, which is considered to be the molecular cause of the disease," said Aisen. "This is the most advanced anti-amyloid treatment that exists--it has the potential for slowing down progression of the disease."

Aisen and his team are currently in the midst of Phase III clinical trials on tramiprosate (manufactured by Neurochem, for which Aisen is a scientific advisor, as ALZHEMEDTM) and hope to have results by early next summer. Media should call 202-687-5100 to schedule an interview with Aisen or to be connected with another Georgetown expert on the topic.


'"/>

Contact: Becky Wexler
rjw43@georgetown.edu
202-687-5100
Georgetown University Medical Center
2-Nov-2006


Page: 1

Related medicine news :

1. New study shows promise in reducing surgical risks associated with surgical bleeding
2. Most seniors now have drug coverage, U-M study shows
3. Wireless technology shows promise in diagnosing pediatric intestinal disease
4. Study shows radiofrequency ablation highly effective in treating kidney tumors
5. Method shows promise for early detection of pancreatic cancer
6. Organic farming can feed the world, U-M study shows
7. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
8. Borderline personality disorder shows improvements with intensive psychotherapy
9. New drug shows promise in treatment of advanced thyroid cancer
10. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
11. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/11/2019)... , ... January 11, 2019 , ... In Partnership with ... dental services for low-income, underinsured individuals at its Burleson, TX office on ... and x-rays, fillings, cleanings and extractions . For more information, please ...
(Date:1/11/2019)... ... January 11, 2019 , ... ... radio station, WJR-760. , Dr. Jonathan Zaidan, President of Women’s Excellence, will co-host ... the third Wednesday of each month at 7pm. , "We are excited to ...
(Date:1/10/2019)... ... ... Tuesday, January 8, Dr. Samuel Joseph, Jr. , assisted by Dr. Andrew Moulton ... Systems revolutionary 3D Printed Aries Titanium Spinal Implant . “As a surgeon, it’s ... life so quickly,” commented Dr. Joseph, founder of Joseph Spine. “Today we were able to ...
(Date:1/10/2019)... , ... January 10, 2019 , ... ... introducing their Cellulose Tencel CBD Infused Face Mask. CBD, or Cannabidiol, is one ... properties research has shown that CBD influences receptors that are naturally present in ...
(Date:1/8/2019)... (PRWEB) , ... January 08, 2019 , ... ... East Point, Morrow, South DeKalb and West End communities have a new option ... to their network, effective immediately. , JenCare operates five centers in Atlanta ...
Breaking Medicine News(10 mins):
(Date:1/14/2019)... ... 14, 2019 , ... The Isagenix Legacy Foundation ... nonprofits that align with its mission to provide healthy nutrition and support for ... disasters. Located in Arizona, California, Georgia, Massachusetts, Maryland, Michigan, and Montana, the nonprofits ...
(Date:1/14/2019)... ... ... Sigma Theta Tau International Honor Society of Nursing (Sigma) was awarded two 2018 American ... one of the most important and prestigious designations of excellence in nursing book publishing. ... Sigma for the last 10 consecutive years. , Following are the Sigma books recognized ...
(Date:1/14/2019)... BOLOGNA, Italy (PRWEB) , ... January 13, 2019 , ... ... markets, is proud to announce the Memor™ 10 rugged mobile computer , one ... , MEMOR™ 10 is part of a new family of rugged Android PDA ...
Breaking Medicine Technology:
Cached News: